Regeneron

Regeneron A biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines We do not interview candidates on Google Hangouts.

Please visit http://www.Regeneron.com/social-media-terms for more information on how to engage with Regeneron on social media. Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. Any questions about job listings can be directed to [email protected]. R

egeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases. Commenting Guidelines
Thank you for visiting our page. This is a place where we hope you will engage with and learn more about our company and take part in open dialogue that respects other members. We want to hear from you and we’ll respond to your comments and questions as soon as possible. We respect your right to voice your opinions, but we reserve the right to remove any comments that are considered inappropriate, off-topic, or abusive. Please don’t use this page to solicit for third-party sites or products. Comments that are factually inaccurate or misleading, violate another's copyright or intellectual property, use profanity or are defamatory will be deleted. The content you read here may contain information related to health, medical and fitness conditions and treatment. It is for informational purposes only and not a substitute for professional medical advice, diagnosis, or treatment. Please always consult your doctor. All comments, visuals, videos and other type of material posted by fans on this site ("User Content") do not necessarily reflect the opinions or ideals of Regeneron, its employees or affiliates. Regeneron assumes no responsibility for the User Content on the page, nor for any error, defamation, libel, slander, omission falsehood, obscenity, pornography, profanity, danger or inaccuracy contained in any User Content. You understand and agree that User Content will be treated as non-confidential and non-proprietary and you are giving us and our affiliates, a royalty-free, irrevocable, perpetual, non-exclusive and fully sublicensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such User Content in whole or in part, on a worldwide basis, and to incorporate them in other works, in any form, media, technology, or products now known or later developed, including for promotional or marketing purposes; and you further represent, warrant, and covenant that you have and will continue to have the legal right to grant these rights. Please read Facebook's Statements of Rights and Responsibilities for more information. Adverse Events
This page is not the best place to discuss safety issues or side effects associated with our products or other company’s products. If you, or someone you know, may have possibly experienced a side effect while taking a Regeneron product please contact our Medical Information Department at 1-855-REGEN-4-U (1-855-734-3648) for further information. You can also report any adverse event directly to your healthcare provider or to the U.S. Food and Drug Administration (FDA) by calling 1-800-FDA-1088 or visiting http://www.fda.gov/Safety/MedWatch.

26/05/2026

A week of discovery, collaboration, and global connection 🌍

The 2026 Regeneron International Science and Engineering Fair (ISEF), a program of Society for Science, brought together 1,700+ students from ~70 nations to present their research and compete for over $7M in awards and prizes on a global stage.

Selected from classrooms worldwide, these students shared ideas, connected across cultures and explored how their work can make a real-world impact.

For many, ISEF is an experience that extends far beyond the competition – shaping how they think about science, collaboration and the future.

Learn more: https://bit.ly/3PkUJpC

20/05/2026

Building a legacy in clinical research is more than data.

It’s built through trust. Through dedication. Through the lives impacted by today’s clinical trials.

This , we honor the people behind clinical trials—like investigator Dr. Dipenkumar Modi—who help move science forward.

Clinical trials matter. Learn why: https://bit.ly/46VX3ZG

18/05/2026

Non-melanoma skin cancers (NMSCs), including basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (CSCC), are the most common types of skin cancer in the U.S. and can progress to become advanced.

While anyone can be diagnosed with BCC or CSCC, some people may be more at risk than others. This , take the pledge ✋ to get an annual skin check on our Let’s Get Real About Skin Cancer website: https://bit.ly/4ndVw8b

Meet the winners of the Regeneron International Science and Engineering Fair (ISEF). ISEF, a program of Society for Scie...
15/05/2026

Meet the winners of the Regeneron International Science and Engineering Fair (ISEF).

ISEF, a program of Society for Science, is the world’s largest global STEM competition for high school students, bringing together top young scientists from around the world to compete for nearly $7 million in awards and scholarships.

This year’s winners were selected from classrooms around the world, whose research demonstrates innovation, curiosity, and the potential to address real-world challenges.

Congratulations to this year’s finalists and winners! 🎉

Learn more about the 2026 ISEF winners: https://bit.ly/3PkUJpC

08/05/2026

When models do not act like people, promising medicines may hit delays or dead ends. Guided by innovation principles championed by our co-founder and CSO, George D. Yancopoulos, we built VelociGene® to create fully humanized immune system models that reflect human biology earlier in research. This helps us focus on stronger potential therapeutic candidates, sooner.

Watch to learn more. https://bit.ly/4uuFoS8

06/05/2026

We’re getting ready for the Regeneron International Science and Engineering Fair (ISEF) in Arizona, the world’s biggest science fair and a program of Society for Science. 🌍

As we look ahead, we’re reflecting on what last year’s finalists and judges shared: friendships across continents, research reshaped by new perspectives, and the realization that work started in a school lab can matter on a global scale. We can’t wait to welcome this year’s finalists!

Learn more: https://bit.ly/4tTORml

05/05/2026

Test your knowledge on non-melanoma skin cancers (NMSCs) this !

Check out our Let’s Get Real About Skin Cancer website to learn how to spot the signs of NMSCs, like basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (CSCC), which can progress to become advanced: https://bit.ly/3QVTOMA

23/04/2026

Today, we are proud to announce that the U.S. FDA has approved our medicine – the first and only gene therapy for genetic hearing loss – which will be made available for free in the U.S. 🧬👂

The approval signals a new era in the treatment of genetic forms of hearing loss where enabling 24/7 natural hearing is now possible.

As our first approved gene therapy, this unprecedented breakthrough reflects our approach to continually push the bounds of science to benefit humanity.

Learn more: https://bit.ly/4e6f2Rx

21/04/2026

At Regeneron, we’re in it for good. For the people who need more treatment options and for the breakthroughs that can change what’s possible in medicine.

It’s the reason we come to work every day, relentlessly searching for answers. We are in it for the future, pushing the bounds of science to shape the next frontier in medicine. We are in it for the families waiting on answers, for the communities who fuel our purpose.

Discover how we are advancing our mission to bring science to medicine: RegeneronForGood.com

With several ongoing Phase 3 clinical trials evaluating our novel investigational antibodies, Regeneron is working to re...
30/03/2026

With several ongoing Phase 3 clinical trials evaluating our novel investigational antibodies, Regeneron is working to reimagine what’s possible in thrombosis care.

In a new story authored by David Gutstein, we explore the current treatment landscape and the unmet needs many patients continue to face.

Curious how the body’s clotting cascade works? Learn more here: https://bit.ly/48c4QD7

Learn how Regeneron is advancing investigational Factor XI antibodies to help prevent thrombosis while aiming to reduce bleeding risk.

24/03/2026

🌟 As we enter our next decade as the title sponsor for the Regeneron Science Talent Search (STS), we’re taking a moment to look back and celebrate.

Over the past ten years, STS winners have gone on to incredible places.

STS was a turning point for many, a moment that validated their passion for science, shaped their academic choices, and opened doors to opportunities that helped define their careers.

As a proud partner of Society for Science, we’re excited to continue supporting the next generation of innovators who will push the boundaries of what’s possible.

Here’s to the past STS winners and the many future scientists and leaders to come! 🙌🔬✨

Address

NY

Alerts

Be the first to know and let us send you an email when Regeneron posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Regeneron:

  • Want your business to be the top-listed Engineering Company?

Share